Key facts
- Notable investors include Symphony Ventures (California), Intuition(Paris).
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Phase Labs (Biotechnology)
- ·The full record, as it builds
Funding rounds
No funding rounds for Phase Labs (Biotechnology) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Phase Labs (Biotechnology)
Operator of an applied biology lab developing technologies designed to read and write the morphogenetic code of the body. The company works at the intersection of developmental biology, AI, physics, and engineering to program morphogenesis and regenerate the human body.
- Sector
- Healthcare
- HQ
- San Carlos, CA, United States
- Website
- phaselabs.bio/
- Ownership
- Privately Held (backing)
Phase Labs (Biotechnology) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Phase Labs (Biotechnology) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Phase Labs (Biotechnology) in its N-PORT filings yet. We sweep new filings monthly.